What are the incident rates of lung cancer, breast cancer, brain cancer, colorectal cancer, prostate cancer, leukemia, and lymphoma in the US compared to Europe?

Cancer Incidence Rates: US versus Europe

Lung Cancer

Lung cancer incidence rates are higher in Europe compared to the United States, particularly in Central and Eastern Europe. 1

Regional Comparisons

In men:

• Central/Eastern Europe shows the highest incidence at 65.7 per 100,000 1
• North America (including US) has an incidence of 61.2 per 100,000 1
• European projections for 2017 indicated an incidence of 33.3 per 100,000 in males 1

In women:

• North America has the highest incidence at 35.6 per 100,000 1
• Northern Europe shows 21.3 per 100,000 1
• European projections for 2017 indicated an incidence of 14.6 per 100,000 in females 1

Temporal Trends

• US lung cancer incidence has been declining since 1990-1996, with rates decreasing by 0.9% per year 2
• European projections showed a 10.7% drop over 5 years in males 1
• Contrary to the US, death rates in females are increasing in Europe 1
• Between 2000-2012, the US showed a consistent downward trend in lung cancer incidence, more prominent in men 3

Current Burden

• An estimated 2.2 million new lung cancer cases occurred globally in 2020 3
• Lung cancer remains the leading cause of cancer death in both the US and Europe, accounting for 24% of cancer deaths in European males and 15% in European females 1

Breast Cancer

The provided evidence does not contain specific comparative incidence data for breast cancer between the US and Europe. However, limited information suggests:

• US breast cancer incidence showed a slow increase of 0.5% annually during 2014-2018 4
• Breast cancer is the second most common cancer diagnosis in women after lung cancer globally 5

Colorectal Cancer

The evidence provided does not contain specific comparative incidence rates for colorectal cancer between the US and Europe. The available data only references colorectal cancer in the context of dietary studies and metastatic patterns 1, 6

Prostate Cancer

The evidence provided does not contain specific comparative incidence rates for prostate cancer between the US and Europe. Limited US data shows:

• Prostate cancer incidence remained stable during 2014-2018 4
• Advanced disease increased by 4-6% annually since 2011 in the US 4
• The proportion of distant-stage diagnoses increased from 3.9% to 8.2% over the past decade in the US 4

Brain Cancer (Glioma)

The evidence provided does not contain specific comparative incidence rates for brain cancer between the US and Europe. The available references only mention brain cancer in the context of dietary studies 1

Leukemia

The evidence provided does not contain specific comparative incidence rates for leukemia between the US and Europe. Limited US data shows:

• Male leukemia incidence showed statistically significant decreases during 1990-1996 2
• Childhood leukemia is mentioned only in dietary intervention studies 1

Lymphoma

The evidence provided does not contain specific comparative incidence rates for lymphoma between the US and Europe. The available data only references lymphoma in dietary studies and as a source of lung metastases 1, 6

Important Caveat

The provided evidence is heavily weighted toward lung cancer epidemiology, with minimal data on the other requested cancer types. The lung cancer data is robust and comes from high-quality guidelines from the American College of Chest Physicians and ESMO 1, while data for breast, colorectal, prostate, brain cancers, leukemia, and lymphoma is either absent or insufficient for meaningful US-Europe comparisons in the provided evidence.